{"id":13791,"date":"2017-07-20T11:31:52","date_gmt":"2017-07-20T09:31:52","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13791"},"modified":"2022-09-15T12:53:18","modified_gmt":"2022-09-15T10:53:18","slug":"de-andres-nogales-f-oyaguez-i-alvarez-sala-la-garcia-bragado-f-navarro-a-gonzalez-p-elias-i-soto-j","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/de-andres-nogales-f-oyaguez-i-alvarez-sala-la-garcia-bragado-f-navarro-a-gonzalez-p-elias-i-soto-j\/","title":{"rendered":"de Andr\u00e9s-Nogales F, Oyag\u00fcez I, Alvarez-Sala LA, Garc\u00eda-Bragado F, Navarro A, Gonz\u00e1lez P, El\u00edas I, Soto J"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13495 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/06\/pharmacoeconomics_spanish_research_articles-1.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p style=\"text-align: justify;\"><strong>de Andr\u00e9s-Nogales F, Oyag\u00fcez I, Alvarez-Sala LA, Garc\u00eda-Bragado F, Navarro A, Gonz\u00e1lez P, El\u00edas I, Soto J<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">An\u00e1lisis coste-efectividad y coste-utilidad de apixaban frente a dabigatr\u00e1n y rivaroxaban en el tratamiento y prevenci\u00f3n secundaria del tromboembolismo venoso<\/h6>\n<h6 style=\"text-align: justify;\"><strong>Pharmacoecon Span Res Artic. 2017;14:7-18<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs40277-016-0064-8.pdf\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>de Andr\u00e9s-Nogales F, Oyag\u00fcez I, Alvarez-Sala LA, Garc\u00eda-Bragado F, Navarro A, Gonz\u00e1lez P, El\u00edas I, Soto J &nbsp; &nbsp; An\u00e1lisis coste-efectividad y coste-utilidad de apixaban frente a dabigatr\u00e1n y rivaroxaban en el tratamiento y prevenci\u00f3n secundaria del tromboembolismo venoso Pharmacoecon Span Res Artic. 2017;14:7-18 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,915,304],"tags":[],"class_list":["post-13791","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-cardiovascular","category-pharmacoeconomics-spanish-research-articles","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13791"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13791"}],"version-history":[{"count":2,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13791\/revisions"}],"predecessor-version":[{"id":22438,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13791\/revisions\/22438"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}